KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Capital Expenditures (2017 - 2025)

Guardant Health (GH) has disclosed Capital Expenditures for 9 consecutive years, with $27.8 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 324.56% to $27.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $48.3 million through Dec 2025, up 1168.21% year-over-year, with the annual reading at $48.3 million for FY2025, 1168.21% up from the prior year.
  • Capital Expenditures hit $27.8 million in Q4 2025 for Guardant Health, up from $10.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $40.1 million in Q3 2021 to a low of -$59.2 million in Q4 2022.
  • Historically, Capital Expenditures has averaged $4.5 million across 5 years, with a median of $5.8 million in 2021.
  • Biggest five-year swings in Capital Expenditures: soared 3764.02% in 2021 and later crashed 404.17% in 2024.
  • Year by year, Capital Expenditures stood at -$41.5 million in 2021, then plummeted by 42.51% to -$59.2 million in 2022, then surged by 106.89% to $4.1 million in 2023, then plummeted by 404.17% to -$12.4 million in 2024, then soared by 324.56% to $27.8 million in 2025.
  • Business Quant data shows Capital Expenditures for GH at $27.8 million in Q4 2025, $10.4 million in Q3 2025, and $5.6 million in Q2 2025.